Loading...
An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial
BACKGROUND: The number of injections in the dose escalation of subcutaneous immunotherapy (SCIT) is small for some currently used hypoallergenic allergoids, but can still be inconvenient to patients and can impair compliance. The aim of this trial was to compare safety and tolerability of an acceler...
Na minha lista:
| Udgivet i: | Clin Transl Allergy |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736162/ https://ncbi.nlm.nih.gov/pubmed/26839682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0093-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|